This is especially true for older adults with type 2 diabetes (T2D) taking insulin and/or sulfonylureas — steadfast older ...

An army doctor successfully saved the life of a 75-year-old man mid-flight by recognising and treating the signs of hypoglycemia, which can cause coma or even death if not treated in time. The ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. A new stem cell ...

According to a Phase 3 trial published in The Lancet Diabetes & Endocrinology, a once-weekly combination of semaglutide and ...

A wearable technology developed by Technion Professor Hossam Haick and colleagues in China enables real-time, noninvasive ...

The new implant contains a reservoir of glucagon that sits beneath the skin and can be activated in an emergency, with no need for injections. For individuals with Type 1 diabetes, the risk of ...

India accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India ...

Lupin receives USFDA approval for generic diabetes medications, including Liraglutide Injection and Glucagon for Injection.

For individuals with Type 1 diabetes, the risk of hypoglycemia, dangerously low blood sugar, is a constant concern. When ...

A wearable technology developed by Technion Professor Hossam Haick and colleagues in China enables real-time, non-invasive tracking and optimized treatment for diabetic patients.

Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that management will ...